BDS
BIVV

Banco de Sabadell’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Banco de Sabadell’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-280
Closed -$15K – 434
2017
Q4 		$15K Buy
+280
New +$15.3K ﹤0.01% 285

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Banco de Sabadell's BIVV Position: Q1 2018 in Review

Banco de Sabadell sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 280 shares — an estimated $15K sold.

Banco de Sabadell first reported a position in BIVV in Q4 2017 and held it in 1 quarter. The position peaked at $15K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Banco de Sabadell reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Banco de Sabadell sold 280 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $15K.
  • Banco de Sabadell first reported a position in Bioverativ Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Banco de Sabadell's Bioverativ Inc. Common Stock position peaked at $15K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Banco de Sabadell's 13F filing for Q1 2018, filed 16 May 2018.